SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (13797)1/27/1998 11:58:00 PM
From: David Bogdanoff  Read Replies (7) | Respond to of 32384
 
Henry;

Do you see any negatives to a LLY/WLA combo for Ligand. One analyst published a report which perceives these big pharma combos as putting a squeeze on some biotechs. There could be duplication of research efforts which would be eliminated in a merger as part of a typical cost cutting strategy. Also, fewer big pharmas mean fewer potential partners. Comments anyone?

David